SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivimed Labs soars on announcing transfer and sale of identified products

25 Jul 2016 Evaluate

Vivimed Labs is currently trading at Rs. 77.00, up by 2.30 points or 3.08% from its previous closing of Rs. 74.70 on the BSE.

The scrip opened at Rs. 76.50 and has touched a high and low of Rs. 80.00 and Rs. 76.35 respectively. So far 42482 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 97.00 on 12-Jan-2016 and a 52 week low of Rs. 46.94 on 25-Aug-2015.

Last one week high and low of the scrip stood at Rs. 80.00 and Rs. 73.60 respectively. The current market cap of the company is Rs. 623.85 crore.

The promoters holding in the company stood at 36.79%, while Institutions and Non-Institutions held 2.62% and 60.59% respectively.

Vivimed Labs has announced the transfer and sale of identified products along with their associated trademarks by its wholly owned subsidiary Company, Klar Sehen. As part of this transaction, Klar Sehen will divert certain products within its portfolio to Ordain Healthcare Global, a subsidiary of Spain based Chemo Espana S.A. The total consideration for the identified product lines is Rs 73 crore.

Further, as part of the transaction, Klar Sehen will provide contract manufacturing services for the diversified products for the buyer for an agreed period of time from its two plants located at Hyderabad and Kolkata.

Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.

Vivimed Labs Share Price

6.71 -0.17 (-2.47%)
11-May-2026 13:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.20
Dr. Reddys Lab 1293.20
Cipla 1314.50
Zydus Lifesciences 944.10
Lupin 2265.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×